A Prospective Study of the Relevance of the HLA-G Immune Checkpoint in Cancer Immunotherapy
Clinical trial NCT04300088 · UNKNOWN
Trial details
- NCT number
- NCT04300088
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-03-10
- Primary completion
- 2020-09-10
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.